−1.9 ILS
−9.73 M ILS
14.41 M ILS
About PHARMOCANN GLOBAL
Sector
Industry
CEO
Liran Yechiel Hen Halfon
Headquarters
Ramat Yishai
Founded
1997
ISIN
IL0010968902
FIGI
BBG000PVPD52
Pharmocann Global Ltd. engages in the cultivation, production, storage, and supply of medical cannabis products. It offers cannabis inflorescence and oils. The company was founded by Adi Dagan and Jacob Barak on December 18, 1997 and is headquartered in Ramat Yishai, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PMCN-M is 186.1 ILA — it has increased by 3.10% in the past 24 hours. Watch PHARMOCANN GLOBAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange PHARMOCANN GLOBAL stocks are traded under the ticker PMCN-M.
PMCN-M stock has risen by 15.02% compared to the previous week, the month change is a 59.74% rise, over the last year PHARMOCANN GLOBAL has showed a 12.52% increase.
PMCN-M reached its all-time high on May 16, 2006 with the price of 639,825.3 ILA, and its all-time low was 51.1 ILA and was reached on Mar 26, 2024. View more price dynamics on PMCN-M chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PMCN-M stock is 10.22% volatile and has beta coefficient of 1.36. Track PHARMOCANN GLOBAL stock price on the chart and check out the list of the most volatile stocks — is PHARMOCANN GLOBAL there?
Today PHARMOCANN GLOBAL has the market capitalization of 5.97 M, it has increased by 22.71% over the last week.
Yes, you can track PHARMOCANN GLOBAL financials in yearly and quarterly reports right on TradingView.
PMCN-M net income for the last half-year is −1.45 M ILS, while the previous report showed −2.69 M ILS of net income which accounts for 46.11% change. Track more PHARMOCANN GLOBAL financial stats to get the full picture.
No, PMCN-M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 14.00 employees. See our rating of the largest employees — is PHARMOCANN GLOBAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMOCANN GLOBAL EBITDA is −3.07 M ILS, and current EBITDA margin is −62.05%. See more stats in PHARMOCANN GLOBAL financial statements.
Like other stocks, PMCN-M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMOCANN GLOBAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMOCANN GLOBAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMOCANN GLOBAL stock shows the sell signal. See more of PHARMOCANN GLOBAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.